7:
Prognostic significance of FLT3 internal tandem duplication and NPM1 mutations in acute myeloid leukemia in an unselected patient population.
Suzuki R, Onizuka M, Kojima M, Shimada M, Okamura K, Fukagawa S, Tsuboi K, Kikuchi A, Kobayashi H, Shintani A, Ogawa Y, Kawada H, Hotta T, Ando K.
Int J Hematol. 2007 Dec;86(5):422-8.
PMID: 18192111 [PubMed - indexed for MEDLINE]
Related Articles
9:
Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
Paschka P, Marcucci G, Ruppert AS, Whitman SP, Mrózek K, Maharry K, Langer C, Baldus CD, Zhao W, Powell BL, Baer MR, Carroll AJ, Caligiuri MA, Kolitz JE, Larson RA, Bloomfield CD.
J Clin Oncol. 2008 Oct 1;26(28):4595-602. Epub 2008 Jun 16.
PMID: 18559874 [PubMed - indexed for MEDLINE]
Related Articles
10:
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
Schlenk RF, Döhner K, Krauter J, Fröhling S, Corbacioglu A, Bullinger L, Habdank M, Späth D, Morgan M, Benner A, Schlegelberger B, Heil G, Ganser A, Döhner H; German-Austrian Acute Myeloid Leukemia Study Group.
N Engl J Med. 2008 May 1;358(18):1909-18.
PMID: 18450602 [PubMed - indexed for MEDLINE]
Related Articles
11:
Distinctive expression of myelomonocytic markers and down-regulation of CD34 in acute myelogenous leukaemia with FLT3 tandem duplication and nucleophosmin mutation.
Mori Y, Yoshimoto G, Kumano T, Miyamoto T, Iino T, Takenaka K, Iwasaki H, Harada N, Kinukawa N, Nagafuji K, Teshima T, Shimoda K, Akashi K, Harada M.
Eur J Haematol. 2007 Jul;79(1):17-24.
PMID: 17598835 [PubMed - indexed for MEDLINE]
Related Articles
13:
High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study.
Marcucci G, Maharry K, Whitman SP, Vukosavljevic T, Paschka P, Langer C, Mrózek K, Baldus CD, Carroll AJ, Powell BL, Kolitz JE, Larson RA, Bloomfield CD; Cancer and Leukemia Group B Study.
J Clin Oncol. 2007 Aug 1;25(22):3337-43. Epub 2007 Jun 18.
PMID: 17577018 [PubMed - indexed for MEDLINE]
Related Articles
16:
Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance.
Verhaak RG, Goudswaard CS, van Putten W, Bijl MA, Sanders MA, Hugens W, Uitterlinden AG, Erpelinck CA, Delwel R, Löwenberg B, Valk PJ.
Blood. 2005 Dec 1;106(12):3747-54. Epub 2005 Aug 18.
PMID: 16109776 [PubMed - indexed for MEDLINE]
Related Articles
17:
Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B.
Schlenk RF, Döhner K, Kneba M, Götze K, Hartmann F, Del Valle F, Kirchen H, Koller E, Fischer JT, Bullinger L, Habdank M, Späth D, Groner S, Krebs B, Kayser S, Corbacioglu A, Anhalt A, Benner A, Fröhling S, Döhner H; German-Austrian AML Study Group (AMLSG).
Haematologica. 2009 Jan;94(1):54-60. Epub 2008 Dec 4.
PMID: 19059939 [PubMed - in process]
Related Articles
19:
Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia.
Suzuki T, Kiyoi H, Ozeki K, Tomita A, Yamaji S, Suzuki R, Kodera Y, Miyawaki S, Asou N, Kuriyama K, Yagasaki F, Shimazaki C, Akiyama H, Nishimura M, Motoji T, Shinagawa K, Takeshita A, Ueda R, Kinoshita T, Emi N, Naoe T.
Blood. 2005 Oct 15;106(8):2854-61. Epub 2005 Jun 30.
PMID: 15994285 [PubMed - indexed for MEDLINE]
Related Articles
20:
Rapid detection of Flt3 mutations in acute myeloid leukemia patients by denaturing HPLC.
Bianchini M, Ottaviani E, Grafone T, Giannini B, Soverini S, Terragna C, Amabile M, Piccaluga PP, Malagola M, Rondoni M, Bosi C, Baccarani M, Martinelli G.
Clin Chem. 2003 Oct;49(10):1642-50.
PMID: 14500589 [PubMed - indexed for MEDLINE]
Related Articles